HMGCR and ankylosing spondylitis: Furthermore, on the basis of human genetic evidence in ankylosing spondylitis, a common inflammatory disease, our findings also support the hypothesis that inhibition of HMG-CoA reductase may produce an independent anti-inflammatory effect beyond its lipid-lowering activity.